ResMed Inc.

RMD | NYSE

Price Alert Chart Builder DCF Calculator

$224.47

+$0.86 (+0.38%)

Sep 22, 2026, 2:19 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Jun 29, 2026	FY 2025 Jun 29, 2025	FY 2024 Jun 29, 2024	FY 2023 Jun 29, 2023	FY 2022 Jun 29, 2022	FY 2021 Jun 29, 2021
Revenue	5.65B	5.15B	4.69B	4.22B	3.58B	3.2B
Cost of Revenue	2.2B	2.09B	2.03B	1.87B	1.55B	1.36B
Gross Profit	3.46B	3.05B	2.66B	2.36B	2.02B	1.84B
Operating Income	1.89B	1.69B	1.32B	1.13B	1B	903.68M
Interest Income	n/a	n/a	n/a	n/a	n/a	362K
Pretax Income	1.92B	1.68B	1.26B	1.1B	960.48M	883.66M
Net Income	1.52B	1.4B	1.02B	897.56M	779.44M	474.51M
Selling & General & Admin	817.39M	991.02M	917.14M	874M	739.37M	670.39M
Research & Development	378.29M	331.28M	307.53M	287.64M	253.58M	225.28M
Other Expenses	369.35M	47.3M	110.75M	62.15M	31.08M	39.75M
Operating Expenses	1.57B	1.37B	1.34B	1.22B	1.02B	935.42M
Interest Expense	29.03M	12.61M	45.71M	47.38M	22.31M	23.99M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.76B	3.46B	3.37B	3.09B	2.58B	2.29B
Income Tax Expense	396.12M	276.84M	243.85M	204.11M	181.05M	409.16M
Shares Outstanding (Basic)	144.71M	146.72M	147.02M	146.77M	146.07M	145.31M
Shares Outstanding (Diluted)	144.98M	147.34M	147.55M	147.46M	147.04M	146.45M
EPS (Basic)	10.44	9.55	6.94	6.12	5.34	3.27
EPS (Diluted)	10.40	9.51	6.92	6.09	5.30	3.24
EBITDA	2.15B	1.91B	1.53B	1.36B	1.18B	1.1B
EBIT	1.95B	1.68B	1.31B	1.16B	982.8M	912.35M
Depreciation & Amortization	197.86M	235.81M	216.21M	196.52M	193.84M	191.52M